Bowel Cancer Rise in Under-50s: Is Birth Year a Factor?

The incidence of colorectal cancer is rising among younger adults, a trend that has prompted concern among medical professionals and researchers. While historically a disease primarily diagnosed in individuals over the age of 50, an increasing number of people under 50 are now receiving a colorectal cancer diagnosis.

Data indicates a significant shift in the age demographics of this disease. According to research, those born around 1990 are twice as likely to develop colon cancer and four times as likely to develop rectal cancer compared to those born in 1950. This represents a doubling of bowel cancer cases in individuals under 50 since the early 1990s.

The reasons behind this increase are complex and currently under investigation. Researchers are exploring a combination of genetic, environmental, and lifestyle factors that may be contributing to the trend. While the exact causes remain elusive, the growing number of cases in younger adults has led to a reevaluation of screening guidelines.

In May 2021, the U.S. Preventative Services Task Force lowered the recommended age for initiating colorectal cancer screenings from 50 to 45. This change reflects the increasing prevalence of the disease in younger populations and aims to detect cases at an earlier, more treatable stage. The decision was also influenced by the tragic passing of Chadwick Boseman, the actor known for his role as Black Panther, who died of colon cancer at age 43 after a four-year battle with the disease.

Colorectal cancer develops when cells in the colon or rectum grow out of control. Often, the process begins with the formation of abnormal growths called polyps. Over time, these polyps can transform into cancerous tumors. The American Cancer Society estimates that the lifetime risk of developing colorectal cancer is approximately 1 in 23 for men and 1 in 25 for women.

Recognizing the early signs of colorectal cancer is crucial for timely diagnosis and treatment. Common symptoms include a change in bowel habits, blood in or on the stool, rectal bleeding, diarrhea, constipation, a feeling of incomplete bowel emptying, unexplained weight loss, cramping or abdominal pain, weakness, and fatigue. It’s important to note that these symptoms can also be indicative of other conditions, but any persistent or concerning changes should be evaluated by a physician.

The experience of individuals like Holly Masters highlights the challenges faced by younger patients. Masters, diagnosed with stage-three bowel cancer at age 24, initially had her symptoms dismissed as irritable bowel syndrome (IBS) due to her age and the circumstances of the COVID-19 pandemic. Her case underscores the importance of advocating for oneself and seeking further medical attention when symptoms persist.

Currently, approximately 2,600 individuals under the age of 50 are diagnosed with bowel cancer each year in the UK. While this number represents a relatively small proportion of overall cases – 94 percent of diagnoses occur in those over 50 – the upward trend is significant and warrants further investigation.

Researchers are actively working to understand the factors driving this increase in early-onset colorectal cancer. Studies are examining potential links to diet, obesity, physical inactivity, and changes in the gut microbiome. Genetic predispositions also play a role, and individuals with a family history of colorectal cancer should discuss their risk with their healthcare provider.

The rise in colorectal cancer among younger adults serves as a reminder of the importance of maintaining a healthy lifestyle, being aware of potential symptoms, and seeking medical attention when necessary. While the causes are still being investigated, early detection and treatment remain the most effective strategies for improving outcomes.

As Ryan O’Grady, a 43-year-old mathematics professor, discovered, colorectal cancer can affect individuals at any age. His diagnosis, following persistent gastrointestinal issues, emphasizes the need for vigilance and proactive healthcare, even in the absence of known risk factors.